AAFA
The Asthma and Allergy Foundation of America (AAFA), a not-for-profit organization founded in 1953, is the leading patient organization for people with asthma and allergies, and the oldest asthma and allergy patient group in the world.
CERTIFIED Baby Mattress Creates a Healthier Environment for Infants With Asthma and Allergies
Pure Zees recently announced the expansion of its innovative asthma & allergy friendly® mattresses into the U.S. market, unveiling a new U.S. website to...
February Advocacy Update: Over-the-Counter Medicines, Restaurant Safety and Cleaner Cars
Welcome to your February advocacy update. I’m Jenna Riemenschneider, director of Advocacy at the Asthma and Allergy Foundation of America (AAFA). I am pictured...
Clean Economy Act Would Benefit Millions of People With Asthma and Allergies by Addressing...
U.S. Senator Tom Carper (D-Del.), top Democrat on the U.S. Senate Environment and Public Works Committee, was joined by 32 Senators in introducing legislation...
Coronavirus (2019-nCoV): What People With Asthma Need to Know
The 2019 new coronavirus (also known at 2019-nCoV) is a hot topic in the news. Now that it has spread to the U.S., you...
Skip Flowers, Perfume and Candy for Your Valentine With Asthma and Allergies
Flowers, candy, perfume and candles may be common gifts for Valentine’s Day. But if you give them to your loved ones with asthma and...
FDA Considers Biologic Dupilumab for Children Ages 6 to 11 Years With Moderate-to-Severe Atopic...
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
DOT Proposes New Rules for Animals on Planes
On Jan. 22, 2020, the U.S. Department of Transportation (DOT) released proposed rules on animals on planes. If they finalize these rules, airlines would...
Dr. Philip Norman: An AAFA Tribute to an Allergy Legend
If you’ve ever benefited from immunotherapy (allergy shots, SLIT or oral immunotherapy), you can thank Dr. Philip Sidney Norman. Dr. Norman put allergy research...
AAFA CEO and President Testifies in Support of Protections for School Children With Asthma...
On Jan. 8, 2020, Kenneth Mendez, CEO and president of the Asthma and Allergy Foundation of America (AAFA), spoke before members of the U.S....
Help Shape the Future of Asthma Treatment
Share your thoughts on the future of asthma treatment. Take two short surveys by Jan. 12, 2020, 11:59 p.m. ET, and we'll submit your...
We Fight, Support and Advocate in Honor of Those Who Have Lost Their Lives
Dear Friends, One of the hardest things we do at the Asthma and Allergy Foundation of America is have conversations with families who have...
Advances in Asthma and Allergies in 2019
These are just a few things we were able to do this year for the asthma and allergy community because of you. But there...
Congress Expected to Approve Funding That Benefits People With Asthma and Allergies
On Dec. 16, 2019, Congress released a spending package to fund the government for 2020. This plan includes some big wins for the asthma...
LUSTER Clinical Trial Results for People With Uncontrolled Moderate-to-Severe Asthma Announced
Novartis today announced topline results from its pivotal global Phase III LUSTER-11 and LUSTER-22 studies exploring the efficacy and safety of the investigational oral,...
FDA Will Consider Xolair for the Treatment of Nasal Polyps
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application...